The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Melissa Shaw
Tahoe Resources (TSX: THO, NYSE: TAHO) (“Tahoe” or the “Company”) reported today that the Guatemalan Supreme Court issued a decision that reinstates the Escobal mining license of Tahoe’s Guatemalan subsidiary, Minera San Rafael (“MSR”).
This decision reverses the Supreme Court’s preliminary decision to suspend MSR’s license in connection with an action brought by the anti-mining
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
By Melissa Shaw
A court ruling is expected in the next few months; until then, Tahoe will be unable to mine at its Guatemala-based silver mine.
By Shelly Kumar
Nevada Sunrise (TSXV:NEV) announced today that it has received notice from its exploration partner Advantage Lithium Corp. (“Advantage Lithium”) that Advantage Lithium wishes to discontinue its option on the Neptune, Jackson Wash, Aquarius and Gemini lithium projects, all located in Esmeralda County, Nevada.
Advantage Lithium continues to maintain its option on the Clayton
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
A new study evaluating the clinical trials medical devices go through as part of their redesigns or updates found these can often rely on “inadequate or potentially biased data.”
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
Teck Resources Limited (TSX:TECK.A and TECK.B)(NYSE:TECK) (“Teck”) reported profit attributable to shareholders of $577 million ($1.00 per share) in the second quarter compared with $15 million ($0.03 per share) a year ago.
“I’m pleased with our results,” said Don Lindsay, President and CEO. “We generated adjusted EBITDA of $1.3 billion in
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
From Uruguay’s full legalization to the debate between regional leaders in Canada questioning the recreational deadline, and a variety of market news INN provides a roundup of the week in cannabis
LGC Capital announced it entered the medical cannabis space by signing an exclusive agreement to acquire 60 percent interest in House of Hemp.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
By Melissa Shaw
The mining license for Tahoe Resources’ flagship Escobal silver mine has been temporarily suspended. Escobal is one of world’s largest silver mines.
Connect with our Featured Silver Stocks to receive the latest news and investor presentations.